LONP1 and prostate carcinoma: Complex IV depletion has been demonstrated with changes in expression or pathogenic mutations of LONP1 in cells of the lung, heart, liver and muscle, as well as fibroblasts (37–39), but we did not observe differences in Complex II assembly, although this has been previously reported in prostate cancer cells (41).